Mohammad Y. Meah

Array ( [id] => 20771746 [patent_doc_number] => 12655407 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-06-16 [patent_title] => Engineered meganucleases having specificity for a recognition sequence in the hepatitis B virus genome [patent_app_type] => utility [patent_app_number] => 19/347136 [patent_app_country] => US [patent_app_date] => 2025-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 54 [patent_no_of_words] => 48342 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19347136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20567120 [patent_doc_number] => 20260061038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-03-05 [patent_title] => COMBINATION THERAPY WITH ANTIBODY-DRUG CONJUGATES AND HYALURONIDASES [patent_app_type] => utility [patent_app_number] => 19/315951 [patent_app_country] => US [patent_app_date] => 2025-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29391 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19315951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20459616 [patent_doc_number] => 20260009039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-08 [patent_title] => ANTI-MICROBIAL AND UV-PROTECTIVE EXTRACTS AND METHODS OF MAKING AND USING THEREOF [patent_app_type] => utility [patent_app_number] => 19/312553 [patent_app_country] => US [patent_app_date] => 2025-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31355 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19312553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20426826 [patent_doc_number] => 20250388914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-12-25 [patent_title] => UV-RESISTANT BIOLOGICAL DEVICES AND EXTRACTS AND METHODS FOR PRODUCING AND USING THE SAME [patent_app_type] => utility [patent_app_number] => 19/312528 [patent_app_country] => US [patent_app_date] => 2025-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14230 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19312528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20676454 [patent_doc_number] => 20260115263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-04-30 [patent_title] => Hyaluronidase Enzyme Formulations for High Volume Administration [patent_app_type] => utility [patent_app_number] => 19/307581 [patent_app_country] => US [patent_app_date] => 2025-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84667 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19307581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20426599 [patent_doc_number] => 20250388686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-12-25 [patent_title] => COMPOSITIONS OF IL-1R1 ANTIBODIES AND METHODS OF PRODUCING AND USING THE SAME [patent_app_type] => utility [patent_app_number] => 19/273461 [patent_app_country] => US [patent_app_date] => 2025-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53219 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19273461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20729106 [patent_doc_number] => 12636350 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-05-26 [patent_title] => Hyaluronidase enzyme formulations for high volume administration [patent_app_type] => utility [patent_app_number] => 19/242226 [patent_app_country] => US [patent_app_date] => 2025-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 199 [patent_figures_cnt] => 226 [patent_no_of_words] => 85054 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19242226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20231372 [patent_doc_number] => 20250288691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-18 [patent_title] => COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF HBV GENE EXPRESSION [patent_app_type] => utility [patent_app_number] => 19/224549 [patent_app_country] => US [patent_app_date] => 2025-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73854 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19224549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19989643 [patent_doc_number] => 20250127865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-24 [patent_title] => Hyaluronidase Enzyme Formulations for High Volume Administration [patent_app_type] => utility [patent_app_number] => 18/940001 [patent_app_country] => US [patent_app_date] => 2024-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84526 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18940001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19989644 [patent_doc_number] => 20250127866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-24 [patent_title] => Hyaluronidase Enzyme Formulations for High Volume Administration [patent_app_type] => utility [patent_app_number] => 18/940031 [patent_app_country] => US [patent_app_date] => 2024-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 83591 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18940031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19832636 [patent_doc_number] => 20250084422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-13 [patent_title] => Recombinant of Hydrogenophilus Bacterium with Enhanced Ability to Produce Valine [patent_app_type] => utility [patent_app_number] => 18/937712 [patent_app_country] => US [patent_app_date] => 2024-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9306 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 212 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18937712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20144202 [patent_doc_number] => 12378532 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-05 [patent_title] => Food composition containing novel aldehyde dehydrogenase for improving memory and cognitive function [patent_app_type] => utility [patent_app_number] => 18/935987 [patent_app_country] => US [patent_app_date] => 2024-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 28 [patent_no_of_words] => 7423 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18935987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19845293 [patent_doc_number] => 20250090644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-20 [patent_title] => E. COLI EXPRESSED RECOMBINANT HUMAN MICROPLASMIN, A PRODUCTION METHOD THEREOF, A PHARMACEUTICAL COMPOSITION AND A KIT COMPRISING THEREOF, A METHOD AND AN APPLICATION OF TREATING THROMBOEMBOLISM RELATED DISEASES BY USING THEREOF [patent_app_type] => utility [patent_app_number] => 18/899715 [patent_app_country] => US [patent_app_date] => 2024-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14018 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18899715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19709277 [patent_doc_number] => 20250019419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-16 [patent_title] => PRODUCTION METHOD FOR PRODUCT AND PRODUCT [patent_app_type] => utility [patent_app_number] => 18/898929 [patent_app_country] => US [patent_app_date] => 2024-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9509 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18898929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19875839 [patent_doc_number] => 20250108096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-03 [patent_title] => ALCOHOL CLEANSING METHODS [patent_app_type] => utility [patent_app_number] => 18/900033 [patent_app_country] => US [patent_app_date] => 2024-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21126 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18900033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19693188 [patent_doc_number] => 20250011733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => BIOCATALYSTS FOR EZETIMIBE SYNTHESIS [patent_app_type] => utility [patent_app_number] => 18/886292 [patent_app_country] => US [patent_app_date] => 2024-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28585 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18886292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19890582 [patent_doc_number] => 20250115894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-10 [patent_title] => Three-dimensional model of exposed microbial membranes at gas-liquid interface and preparation method thereof [patent_app_type] => utility [patent_app_number] => 18/885576 [patent_app_country] => US [patent_app_date] => 2024-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7515 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 789 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18885576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19940495 [patent_doc_number] => 12312617 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-05-27 [patent_title] => Cell wall hydrolases targeting c. acnes [patent_app_type] => utility [patent_app_number] => 18/882341 [patent_app_country] => US [patent_app_date] => 2024-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 62 [patent_no_of_words] => 41227 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18882341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20165330 [patent_doc_number] => 20250257376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-14 [patent_title] => GENERATION OF ACYL ALCOHOLS [patent_app_type] => utility [patent_app_number] => 18/828699 [patent_app_country] => US [patent_app_date] => 2024-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13340 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18828699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19940497 [patent_doc_number] => 12312619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-05-27 [patent_title] => Deaminases and variants thereof for use in base editing [patent_app_type] => utility [patent_app_number] => 18/814865 [patent_app_country] => US [patent_app_date] => 2024-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 19 [patent_no_of_words] => 14813 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18814865 [rel_patent_id] =>[rel_patent_doc_number] =>)